The PTAB is getting harder to enter, even as fewer petitions are being filed.
In Q1 2026, new IPR filings dropped to 119, the lowest point across the tracked period. But fewer filings did not improve the petitioner’s success.
Denials still outnumbered institutions. Parallel litigation, trial timing, weak motivation to combine arguments, and claim-mapping gaps now determine whether a petition is reviewed or stopped at the door.
This report breaks down what changed in Q1 2026 and what petitioners, patent owners, and litigation teams need to adjust next.
Key Insights from Q1 2026 PTAB Report
1. Filing Volume Fell, But Institution Did Not Become Easier
New IPR filings fell 37% from Q4 2025 and 66% from the Q2 2025 peak.
Petitioners are filing fewer cases, yet the PTAB continues to apply a strict institution filter. In Q1 2026, denials continued to outnumber institutions, with 90 denials against 51 institutions in the broader quarterly dataset.
What this means:
Selective filing is not enough. Petitioners need stronger timing, cleaner grounds, and tighter claim mapping before filing.
2. Fintiv Remains the Main Reason Strong Petitions Fail
Discretionary denials based on parallel district court litigation accounted for 60.5% of all denials.
The report shows that petitions tied to advanced litigation, especially in the E.D. Texas and W.D. Texas faces a high risk of denial before the Board reaches the technical merits.
Strategic takeaway:
Prior art strength no longer protects a petition by itself. Filing early, seeking a litigation stay, and tracking district court trial dates now matter as much as the art.
3. Weak Motivation-to-Combine Arguments Are Still a Major Petition Risk
Petitions with weak motivation-to-combine arguments had a far lower grant rate than petitions with strong MTC support.
Common failure patterns included four-reference combinations, hindsight-based arguments, incompatible references, and expert declarations that repeated the petition without adding technical reasoning.
What this means:
The Board is not rewarding long, overloaded petitions. It is looking for clear technical reasons why a person skilled in the art would combine the references.
4. Claim Mapping Gaps Can Decide the Outcome
Claim mapping gaps were one of the strongest predictors of denial.
When the petition failed to map prior art clearly to claim limitations, institution rates dropped sharply. Expert testimony did not fix weak mapping when the declaration was not tied to the cited art.
Lesson:
A strong IPR starts with clean, limitation-by-limitation mapping. Broad prior art arguments are not enough.
5. Technology Sector Still Shapes PTAB Outcomes
Institution rates varied across sectors.
Bio-pharma showed stronger institution performance in Q1 2026 as petitioners filed fewer but more targeted challenges. Electrical and computer technologies continued to face pressure from discretionary denials and parallel litigation. Semiconductor and energy cases showed stronger results where prior art was specific, and litigation pressure was lower.
Implication:
PTAB strategy should not be copied across technologies. The same filing approach may work in semiconductor cases but fail in FinTech, wireless, or automotive disputes.
6. Petitioners Still Have the Advantage After Institution
Once a case reached Final Written Decision, petitioners remained in a strong position.
In Q1 2026, petitioners secured full invalidation in 61% of FWD outcomes, while patent owners fully preserved claims in only 15% of cases. Mixed outcomes remained common and often left both sides under pressure to settle and appeal.
What this means:
The hardest battle is now institution. Once a petition enters trial, the challenger often holds the stronger position.
7. NPEs Are Using Fintiv More Effectively
NPE-owned patents saw higher petition denial rates than operating company-owned patents.
The report shows that NPEs often benefit from fast-moving parallel litigation and focused discretionary denial arguments. This gives them a stronger pre-institution defense, even when the petitioner has serious prior art.
Strategic takeaway:
Defendants facing NPE litigation need to preserve the IPR window early. Waiting until the district court schedule matures can close the PTAB route.
Get the Full Analysis
The complete report includes:
- Detailed Q1 2026 institution and denial statistics
- Fintiv and parallel litigation risk patterns
- Prior art and rejection ground success rates
- Technology-specific PTAB outcomes
- Petitioner, patent owner, law firm, and attorney performance data
- Weak MTC and claim mapping failure patterns
- FWD outcome trends and settlement signals
- Forward-looking PTAB strategy for 2026
